Home › NCT05514730
Treatment for Problematic Sexual Behavior of Preteen Children
Who can join
Ages 4 to 12 · All sexes
Full eligibility criteria
Inclusion Criteria: * Child between ages 4 and 12 years * Caregiver reports a raw score on the CSBI greater than 4. * A primary caregiver is willing to participate in treatment. * Child earns a scaled score above 69 on the Kaufman Brief Intelligence Test (KBIT-2) * Child proficient in spoken English * Caregiver proficient in written and spoken English. Exclusion Criteria: * Child is less than 4 years of age or older than 12 years of age. * Caregiver reports a score on the CSBI lower than 4 * A primary caregiver is unwilling to participate in treatment. * Child scored lower than 70 on the KBIT-2. * The primary caregiver is suspected of perpetrating child sexual abuse. * Child not proficient in spoken English. * Caregiver not proficient in both written and spoken English.
About the study
Relatively little is known about the treatment of problematic sexual behavior (PSB) displayed by preteen children. Randomized controlled trials (RCTs) examining potential treatments are rare and the available results to date are generally underwhelming. A new protocol, termed Phase-Based Treatment (PBT) for Preteen PSB, has shown positive results in an early stage pilot and during community implementation efforts. This trial will be the first RCT of PBT and aim to determine whether PBT might outperform a treatment-as-usual condition.
What is being tested
- Phase-based Treatment (PBT) for Problematic Sexual Behavior of Preteen Children (behavioral)
- Treatment-as-Usual (TAU) (behavioral)
Sponsor: Milton S. Hershey Medical Center · Participants: 42 · Started: Jan 9, 2023
Contact the study team
- Brian Allen, PsyD · Phone: 7175314100
Official record on ClinicalTrials.gov — NCT05514730
Locations in the U.S.
| Pennsylvania | Penn State Hershey Medical Center-TLC Research and Treatment Center, Harrisburg |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.